These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16280683)

  • 1. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
    Cookson MR; Xiromerisiou G; Singleton A
    Curr Opin Neurol; 2005 Dec; 18(6):706-11. PubMed ID: 16280683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of recent genetic findings in Parkinson's disease.
    Klein C; Lohmann-Hedrich K
    Curr Opin Neurol; 2007 Aug; 20(4):453-64. PubMed ID: 17620882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the genetics of Parkinson's disease.
    Gasser T
    Mov Disord; 2007 Sep; 22 Suppl 17():S343-50. PubMed ID: 18175395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The curious case of phenocopies in families with genetic Parkinson's disease.
    Klein C; Chuang R; Marras C; Lang AE
    Mov Disord; 2011 Aug; 26(10):1793-802. PubMed ID: 21735483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
    Khan NL; Jain S; Lynch JM; Pavese N; Abou-Sleiman P; Holton JL; Healy DG; Gilks WP; Sweeney MG; Ganguly M; Gibbons V; Gandhi S; Vaughan J; Eunson LH; Katzenschlager R; Gayton J; Lennox G; Revesz T; Nicholl D; Bhatia KP; Quinn N; Brooks D; Lees AJ; Davis MB; Piccini P; Singleton AB; Wood NW
    Brain; 2005 Dec; 128(Pt 12):2786-96. PubMed ID: 16272164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What genetics tells us about the causes and mechanisms of Parkinson's disease.
    Corti O; Lesage S; Brice A
    Physiol Rev; 2011 Oct; 91(4):1161-218. PubMed ID: 22013209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Parkinson's disease.
    Bonifati V
    Minerva Med; 2005 Jun; 96(3):175-86. PubMed ID: 16175160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.
    Gaig C; Martí MJ; Ezquerra M; Rey MJ; Cardozo A; Tolosa E
    J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):626-8. PubMed ID: 17210620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease: from monogenic forms to genetic susceptibility factors.
    Lesage S; Brice A
    Hum Mol Genet; 2009 Apr; 18(R1):R48-59. PubMed ID: 19297401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of gene discovery in Parkinson's disease and parkinsonism.
    Wider C; Foroud T; Wszolek ZK
    Mov Disord; 2010; 25 Suppl 1():S15-20. PubMed ID: 20187245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of Parkinson's disease.
    Yang YX; Wood NW; Latchman DS
    Neuroreport; 2009 Jan; 20(2):150-6. PubMed ID: 19151598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian forms of Parkinson's disease.
    Gasser T
    Biochim Biophys Acta; 2009 Jul; 1792(7):587-96. PubMed ID: 19168133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical genetics of Parkinson's disease and related disorders.
    Wider C; Wszolek ZK
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S229-32. PubMed ID: 18267241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease.
    Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH
    Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.